Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.
about
Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Gaza Strip, Palestine.Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in IndiaIntegrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.Urinary tract infections during pregnancy.Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolatesFrequency, urinalysis and susceptibility profile of pathogens causing urinary tract infections in Enugu State, southeast NigeriaTrends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesHigh prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, NepalDiagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.Antibiotic resistance pattern of different Escherichia coli phylogenetic groups isolated from human urinary tract infection and avian colibacillosis.Antibiotic resistance in uropathogenic e. Coli strains isolated from non-hospitalized patients in pakistan.Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decadesAntimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coliVirulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotypeAntimicrobial-resistant invasive Escherichia coli, SpainOccurrence of antibiotic-resistant uropathogenic Escherichia coli clonal group A in wastewater effluentsUropathogen antibiotic resistance in adult women presenting to family physicians with acute uncomplicated cystitis.Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolated From Patients in Kashan, IranRisk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coliLongitudinal Characterization of Escherichia coli in Healthy Captive Non-Human Primates.The treatment of urinary tract infections and use of ciprofloxacin extended release.Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, SudanHigh Frequency of Class 1 Integrons in Escherichia coli Isolated From Patients With Urinary Tract Infections in Yasuj, Iran.High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran.Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in IranComparison of phenotypic characteristics and antimicrobial resistance patterns of clinical Escherichia coli collected from two unrelated geographical areasPhenotypic and Molecular Assessment of Drug Resistance Profile and Genetic Diversity of Waterborne Escherichia coliAntibiograms from community-acquired uropathogens in Gulu, northern Uganda--a cross-sectional study.Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli.Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from VeteransEscherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritisThe clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.A new look at the drug-resistance investigation of uropathogenic E. coli strains.
P2860
Q24815306-331E8361-E91D-4AA9-A0C8-F2984D5D37B9Q28477517-62C633D6-9C9F-4D48-9DCC-E70467C77E95Q30992335-852FFEF4-8E33-4237-8793-D2930108FB70Q33206285-2B75CF84-F65C-4B0D-B4E0-EE0EDFAE865CQ33314977-BC2F4E49-F5A0-46B7-89CF-54930DCB9CC7Q33769703-7CAAED9A-875D-45D2-B79E-C47CDF7E7108Q33859611-7031DFED-563D-4FAA-B21B-548BFC494658Q34110686-19F63E32-10B2-4DE1-927F-1B39A78680ADQ34133230-BBCF6498-AD92-41EF-BD14-2C92963ED10BQ34341884-04911A88-5339-442D-84AD-06E7236A8219Q34475852-09955708-CF11-4041-9693-DE00475E7086Q34479623-E7E392C1-BB96-48CC-BC0F-1277AE8059E7Q34680622-F86013A7-1F3C-4716-BA6F-E9C26C6507CEQ34956171-BD3256DA-B704-4ACF-8472-844D184BDB2BQ35065834-0F33F4BB-08B8-4312-80EB-2AB0E5E7FF33Q35764055-7E7D7932-E7FA-4082-AB4C-4CB4248615E8Q35783832-EAB2ECE3-3643-4B71-B098-5822D5A19E6DQ35867575-FEEAF294-BEB9-4038-8D7F-00905141256DQ35872947-20E795FF-C75C-4E30-A693-778D063AAF48Q35913218-AF286EEA-0756-45E7-96E2-CA94500391ABQ36170882-C2D3B5EE-51F8-41BE-B2CE-57F40F531C47Q36278618-B784F757-035F-44DD-8F33-E8960EB433A4Q36330973-EF6E36B4-9A68-4044-8746-57179AC4A4B9Q36344702-74D0F0D6-BD8A-4663-BE99-DD721D360C43Q36458378-245ECE64-8514-40FD-A844-1889EF4271E3Q36569808-1B4FCA88-FE55-4A9A-9660-5561CCCBE94DQ36578316-E499AF79-A143-488C-B744-84C5EFBD2D12Q36657434-6FE20257-1B22-46A9-AF4D-A761553C6FCFQ36758396-79D76932-410E-4BE8-A06D-97E24E96BBADQ36780495-0C443828-3DFC-4564-82A0-93BCEFF00F32Q36809395-C08EBD5E-CD4B-457D-A9CF-C8D33BA419C5Q36814960-0F80DAD8-392D-492E-991B-07C521BB2725Q36935181-B6D4B5C9-7A89-4DB7-A8C3-CF932B20160FQ37115768-43529B0B-E0EC-4909-BD16-BD705DE5F38DQ37120155-752E1099-7351-4CA9-8879-AC70F6FA99CAQ37220795-D2BF7D19-C0A2-42AD-A2D9-F4723328D515Q37333147-359748A6-159E-4C6E-B9FB-EABFFBC2EA4CQ37335855-828BBECC-E1CC-42AC-916D-2F52BC92B6E7Q37430606-6B29BFAC-B516-429A-A04E-234A821D2276Q37643399-075F6520-27D5-42DC-8674-99A72513A9ED
P2860
Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Multidrug-resistant urinary tr ...... in the United States in 2000.
@ast
Multidrug-resistant urinary tr ...... in the United States in 2000.
@en
type
label
Multidrug-resistant urinary tr ...... in the United States in 2000.
@ast
Multidrug-resistant urinary tr ...... in the United States in 2000.
@en
prefLabel
Multidrug-resistant urinary tr ...... in the United States in 2000.
@ast
Multidrug-resistant urinary tr ...... in the United States in 2000.
@en
P2093
P2860
P1476
Multidrug-resistant urinary tr ...... in the United States in 2000.
@en
P2093
Karlowsky JA
Mayfield DC
Thornsberry C
P2860
P304
P356
10.1128/AAC.45.5.1402-1406.2001
P407
P577
2001-05-01T00:00:00Z